INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 179 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,192 | -10.9% | 40,997 | +2.5% | 0.01% | -16.7% |
| Q2 2023 | $2,461 | +27.5% | 40,000 | +14.3% | 0.01% | +20.0% |
| Q1 2023 | $1,930 | +4.6% | 35,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,846 | -99.9% | 35,000 | -19.0% | 0.01% | -16.7% |
| Q3 2022 | $1,926,000 | -22.4% | 43,219 | -0.8% | 0.01% | -14.3% |
| Q2 2022 | $2,483,000 | -8.6% | 43,583 | -2.1% | 0.01% | 0.0% |
| Q1 2022 | $2,717,000 | +67.2% | 44,500 | +39.9% | 0.01% | +75.0% |
| Q4 2021 | $1,625,000 | +48.4% | 31,800 | +2.9% | 0.00% | +33.3% |
| Q3 2021 | $1,095,000 | -9.3% | 30,900 | 0.0% | 0.00% | -25.0% |
| Q2 2021 | $1,207,000 | +21.6% | 30,900 | 0.0% | 0.00% | +33.3% |
| Q1 2021 | $993,000 | +4.2% | 30,900 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $953,000 | +17.5% | 30,900 | -4.6% | 0.00% | 0.0% |
| Q3 2020 | $811,000 | +64.5% | 32,400 | -50.7% | 0.00% | +33.3% |
| Q3 2019 | $493,000 | -70.5% | 65,700 | -50.0% | 0.00% | -62.5% |
| Q2 2019 | $1,670,000 | -14.1% | 131,400 | +47.8% | 0.01% | -33.3% |
| Q1 2019 | $1,945,000 | +124.1% | 88,900 | +11.5% | 0.01% | +100.0% |
| Q4 2018 | $868,000 | -55.4% | 79,700 | -10.3% | 0.01% | -45.5% |
| Q3 2018 | $1,945,000 | +43.5% | 88,900 | +16.7% | 0.01% | +22.2% |
| Q2 2018 | $1,355,000 | -69.1% | 76,200 | -64.3% | 0.01% | -70.0% |
| Q1 2018 | $4,386,000 | +30.8% | 213,200 | -26.3% | 0.03% | +15.4% |
| Q4 2017 | $3,352,000 | 0.0% | 289,200 | 0.0% | 0.03% | 0.0% |
| Q3 2017 | $3,352,000 | -8.6% | 289,200 | 0.0% | 0.03% | -10.3% |
| Q2 2017 | $3,667,000 | -5.7% | 289,200 | +20.9% | 0.03% | -19.4% |
| Q1 2017 | $3,889,000 | +2409.0% | 239,200 | +2292.0% | 0.04% | +1700.0% |
| Q4 2016 | $155,000 | -94.6% | 10,000 | -86.8% | 0.00% | -93.8% |
| Q2 2016 | $2,845,000 | – | 76,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |